Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/E2Z stock hub

FRA/E2Z has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/E2Zis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/E2Z

In the news

Latest news · FRA/E2Z

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E29.3

P25 n/aP50 n/aP75 n/a

Trailing P/E55.7

P25 n/aP50 n/aP75 n/a

ROE3.1

P25 n/aP50 n/aP75 n/a

ROIC3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/E2Z market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

EUR

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	DE
Employees	2,108
Enterprise value	EUR 2.6B
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 2.6B
Price	EUR 12.06
Price currency	EUR
Rev Per Employee	528,715.37x
Sic	2834
Symbol	fra/E2Z
Website	https://www.almirall.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.8%
EV Earnings	55.82x
EV/EBIT	35.84x
EV/EBITDA	12.16x
EV/FCF	18.46x
EV/Sales	2.31x
FCF yield	5.43%
Forward P/E	29.35x
P/B ratio	1.73x
P/E ratio	55.66x
P/S ratio	2.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.45%
EBITDA Margin	18.23%
FCF margin	12.52%
Gross margin	76.66%
Gross Profit	EUR 854.4M
Gross Profit Growth	13.89%
Gross Profit Growth Q	15%
Gross Profit Growth3 Y	9.13%
Gross Profit Growth5 Y	6.56%
Net Income	EUR 46.2M
Net Income Growth	354.85%
Net Income Growth Q	139.36%
Net Income Growth3 Y	120.91%
Net Income Growth5 Y	-9.08%
Pretax Margin	6.68%
Profit Margin	4.14%
Profit Per Employee	EUR 21,895
ROA	1.9
Roa5y	1.9
ROCE	3.62
ROE	3.1
Roe5y	-0.36
ROIC	3.04
Roic5y	2.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.03%
Cagr15y	4.38%
Cagr1y	19.27%
Cagr3y	13.21%
Cagr5y	0.32%
Div CAGR10	-0.71%
Div CAGR3	-0.36%
Div CAGR5	-1.46%
EPS Growth	354.9
EPS Growth Q	137.9
EPS Growth3 Y	120.9
EPS Growth5 Y	-12.28
FCF Growth	6.58%
FCF Growth Q	-31.08%
FCF Growth3 Y	1.85%
FCF Growth5 Y	6.71%
OCF Growth	8.52%
OCF Growth Q	-48.49%
OCF Growth10 Y	0.21%
OCF Growth3 Y	4%
OCF Growth5 Y	9.12%
Revenue Growth	12.51x
Revenue Growth Q	11.37x
Revenue Growth3 Y	8.26x
Revenue Growth5 Y	6.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.47
Assets	EUR 2.3B
Cash	EUR 338.8M
Current Assets	EUR 714M
Current Liabilities	EUR 350.6M
Debt	EUR 346.5M
Debt EBITDA	EUR 1.63
Debt Equity	EUR 0.23
Debt FCF	EUR 2.48
Equity	EUR 1.5B
Interest Coverage	4.24
Liabilities	EUR 850M
Long Term Assets	EUR 1.6B
Long Term Liabilities	EUR 499.4M
Net Cash	EUR -7.7M
Net Cash By Market Cap	EUR -0.3
Net Debt EBITDA	EUR 0.04
Net Debt Equity	EUR 0.01
Net Debt FCF	EUR 0.06
Tangible Book Value	EUR 486.8M
Tangible Book Value Per Share	EUR 2.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.04
Inventory Turnover	1.49
Net Working Capital	EUR 46.2M
Quick ratio	1.47
Working Capital	EUR 363.3M
Working Capital Turnover	EUR 2.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	EUR 0.15
Dividend Years	11
Dividend Yield	1.24%
Ex Div Date	2025-05-15
Last Dividend	EUR 0.15
Payout Frequency	Annual
Payout Ratio	56.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	0.25%
1Y total return	19.26%
200-day SMA	12.1
3Y total return	45.11%
50-day SMA	12.22
50-day SMA vs 200-day SMA	50over200
5Y total return	1.62%
All Time High	19.18
All Time High Change	-37.12%
All Time High Date	2015-05-28
All Time Low	4.67
All Time Low Change	158.24%
All Time Low Date	2011-11-25
ATR	0.18
Ch YTD	-6.8
High	12.06
High52	13.72
High52 Date	2026-02-19
High52ch	-12.1%
Low	12.06
Low52	9.87
Low52 Date	2025-05-12
Low52ch	22.19%
Ma50ch	-1.28%
Price vs 200-day SMA	-0.33%
RSI	42.15
RSI Monthly	59
RSI Weekly	48.21
Sharpe ratio	0.73x
Sortino ratio	1.28
Total Return	1.24%
Tr YTD	-6.8
Tr15y	90.29%
Tr1m	-1.47%
Tr1w	-3.83%
Tr3m	-6.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 71.9M
Operating Income Growth	42.29
Operating Income Growth Q	-54.59
Operating Income Growth3 Y	2.06
Operating Income Growth5 Y	-8.01
Operating margin	6.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	75,351,701%
Net Borrowing	-74,571,000
Shares Institutions	18.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 139.5M
Average Volume	50x
Bv Per Share	6.92
CAPEX	EUR -34.9M
Ch10y	-12.38
Ch15y	54.81
Ch1m	-1.47
Ch1w	-3.83
Ch1y	17.54
Ch3m	-6.8
Ch3y	38.38
Ch5y	-5.49
Ch6m	2.38
Change	-1.31%
Change From Open	0
Close	12.22
Days Gap	-1.31
Depreciation Amortization	131,319,000
Earnings Date	2026-05-11
EBIT	EUR 71.9M
EBITDA	EUR 203.2M
EPS	EUR 0.22
F Score	7
FCF	EUR 139.5M
FCF EV Yield	5.42x
Financing CF	-87,051,000
Fiscal Year End	December
Founded	1,943
Goodwill	315,966,000
Graham Number	5.83422
Graham Upside	-51.62
Income Tax	EUR 28.3M
Investing CF	-126,736,000
Is Primary Listing	0
Last Earnings Date	2026-02-23
Last Report Date	2025-12-31
Lynch Fair Value	EUR 1.08
Lynch Upside	-91.02
Ma150	12.48
Ma150ch	-3.38%
Ma20	12.62
Ma20ch	-4.47%
Net CF	-39,328,000
Next Earnings Date	2026-05-11
Open	12.06
P FCF Ratio	18.41
P OCF Ratio	14.72
Payment Date	2025-05-25
Ppne	195,209,000
Price Date	2026-05-08
Price EBITDA	EUR 12.64
Ptbv Ratio	5.28
Relative Volume	20x
Revenue	1,114,532,000x
Tax By Revenue	2.54x
Tax Rate	38.01%
Tr6m	2.38%
Z Score	2.42

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/E2Z dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.15 annual per share

Payout ratio

+56.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-1.5%

0 consecutive years of growth

Total shareholder yield

+1.2%

Next ex-dividend date: 2025-05-15

Performance

FRA/E2Z stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/E2Z?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

FRA/E2Z momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.1

Neutral momentum band

Price vs 200-day MA

-0.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/E2Z

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/E2Z stock rating?

fra/E2Z is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/E2Z analysis?

The full report lives at /stocks/fra/E2Z/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/E2Z?

The latest report frames fra/E2Z around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/E2Z page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.